Second Neoplasm
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2) (NCT00638963) | Merck Sharp & Dohme LLC | 2008-10-02 |
Track Second Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.